Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors
暂无分享,去创建一个
Kaoru Tanaka | K. Nishio | K. Azuma | I. Okamoto | J. Tanizaki | K. Nakagawa | Y. Chiba | K. Yonesaka | M. Takeda | K. Sakai | H. Hayashi | S. Atagi | Shinichiro Suzuki | E. Iwama | R. Kato | Satomi Watanabe | T. Takahama | S. Watanabe